Keywords: imclone, profits, reach, 46m, erbitux, sales, drugmaker

ImClone's profits reach $46M on Erbitux sales

Article | 05 February 2007

Print This

US drugmaker ImClone Systems says that its income for the three months ended December 2006 was $46.6 million, or $0.53 per share, up ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in